Novel Use of GLP-1 Receptor Agonist Therapy in HNF4A-MODY.

Broome, David T; Tekin, Zehra; Pantalone, Kevin M; Mehta, Adi E

Broome, David T; Tekin, Zehra; Pantalone, Kevin M; Mehta, Adi E.

Affiliation

Broome DT; Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic Foundation, Cleveland, OH broomed@ccf.org.
Tekin Z; Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic Foundation, Cleveland, OH.
Pantalone KM; Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic Foundation, Cleveland, OH.
Mehta AE; Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic Foundation, Cleveland, OH.

Diabetes Care ; 43(6): e65, 2020 06.

Article de En | MEDLINE | ID: mdl-32265191

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Diabetes Care Année: 2020 Type de document: Article